Toward explaining fixed airflow obstruction in asthma - 03/03/22
Doi : 10.1016/j.jaci.2021.12.784
Sandra Rutting, PhD a, b, Katrina O. Tonga, MBChB, PhD a, b, c, d, e, Gregory G. King, MBChB, PhD a, b, c, ⁎ 
a Department of Respiratory Medicine, Royal North Shore Hospital, St. Leonards, Australia
b Airway Physiology and Imaging Group and Woolcock Emphysema Centre, Woolcock Institute of Medical Research, The University of Sydney, Sydney, Australia
c Faculty of Medicine and Health, The University of Sydney, Sydney, Australia
d Department of Thoracic and Lung Transplant Medicine, St. Vincent’s Hospital, Darlinghurst, Australia
e St. Vincent’s Clinical School, Faculty of Medicine, The University of New South Wales, Sydney, Australia
∗Corresponding author: Gregory G. King, MBChB, PhD, Airway Physiology and Imaging Group, Woolcock Institute of Medical Research, 431 Glebe Point Road, Glebe, NSW, 2037, Australia.Airway Physiology and Imaging GroupWoolcock Institute of Medical Research431 Glebe Point RoadGlebeNSW2037Australia
Key words : Asthma, fixed airflow obstruction, parenchymal remodeling, airway remodeling
Le texte complet de cet article est disponible en PDF.
| S.R. was funded by The Berg Family Foundation. |
|
| Disclosure of potential conflict of interest: The authors declare that they have no relevant conflicts of interest. |
© 2022
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 149 - N° 3
P. 890-892 - mars 2022 Retour au numéro
Article précédent
- 2021: The year in review
- Zuhair K. Ballas
- Bacterial lysates to inhibit allergic airway disease: Are they up to the challenge?
- Christian Taube
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?